CAMBRIDGE, Mass.----Javelin Pharmaceuticals, Inc. announced today that its CEO, Martin J. Driscoll, and Stephen J. Tulipano, CFO, will host a conference call to discuss the Company's quarterly results for the period ending... [read full story]
|
RELATED
|
|
CAMBRIDGE, Mass. - Javelin Pharmaceuticals, Inc. (NYSE Amex: JAV) announced today that its CEO, Martin J. Driscoll, and Stephen J. Tulipano, CFO, will host a conference call to discuss the Company's quarterly results for the...
Senior Management, General Management Issues, CEO, CFO, Massachusetts, North America, United States of America, Cambridge (Massachusetts)
